Primary inflammation in human cystic fibrosis small airways.
Most cystic fibrosis (CF) patients die of lung failure, due to the combined effects of bacterial infection, neutrophil-mediated inflammation, and airway obstruction by hyperviscous mucus. To this day, it remains unclear where and how this pathological vicious circle is initiated in vivo. In particular, it has proven difficult to investigate whether inflammatory pathways are dysregulated in CF airways independently of infection. Also, the relative involvement of large (tracheobronchial) vs. small (bronchiolar) airways in CF pathophysiology is still unclear. To help address these issues, we used an in vivo model based on the maturation of human fetal CF and non-CF small airways in severe combined immunodeficiency mice. We show that uninfected mature CF small airway grafts, but not matched non-CF controls, undergo time-dependent neutrophil-mediated inflammation, leading to progressive lung tissue destruction. This model of mature human small airways provides the first clear-cut evidence that, in CF, inflammation may arise at least partly from a primary defect in the regulation of neutrophil recruitment, independently of infection.
Institut National de la Santé et de la Recherche Médicale U506, 94807 Villejuif, France.
Rabindra
R
Tirouvanziam
Ibrahim
I
Khazaal
Bruno
B
Péault
D000818:Animals; D001980:Bronchi / Q000473:pathology; D002465:Cell Movement; D003550:Cystic Fibrosis / Q000150:complications* / Q000473:pathology; D006801:Humans; D007962:Leukocytes / Q000473:pathology / Q000502:physiology; D008168:Lung / Q000473:pathology; D008407:Mast Cells / Q000473:pathology; D051379:Mice; D016513:Mice, SCID; D009504:Neutrophils / Q000502:physiology; D011014:Pneumonia / Q000209:etiology* / Q000473:pathology; D011650:Pulmonary Alveoli / Q000473:pathology; D012016:Reference Values